Further prospective studies are needed to replicate our RSV-genotype findings in other non-latino populations, and determine if PAI-1 variants may serve as a biomarker of risk, which may provide impetus for clinical trials of primary prevention of asthma. The gene discussed is SERPINE1; the disease is asthma.